Results 291 to 300 of about 203,911 (336)

Reproducibility of Ki67 Haralick entropy as a prognostic marker in estrogen receptor-positive HER2-negative breast cancer. [PDF]

Am J Clin Pathol
Zilenaite-Petrulaitiene D, Rasmusson A, Valkiuniene RB, Laurinaviciene A, Petkevicius L, Laurinavicius A.   +5 more
europepmc   +1 more source

Engineered Small Extracellular Vesicles Targeting Tumor‐Associated Endothelial Cells to Effectively Remodel the Glioma Microenvironment

Advanced Science, EarlyView.
This study developed a novel drug delivery platform that overcomes the blood‐brain barrier in glioblastoma. By fusing IGFBP7 with small extracellular vesicles, the platform specifically targets tumor vasculature. It effectively delivers temozolomide, suppressing tumor growth at low doses.
Lingling Liu, Feiyang Xu, Zhiming Zheng, Xiaodan Yang, Fang Yang, Pei Liu, Yuankun Chen, Yunshu Yang, Junli Zhao, Peiyan Yang, Xiaojing Zheng, Xiaohong Sun, Ping Mao, Qinwen Mao, Hao Guan, Haibin Xia, Weifeng Zhang, Dan Xiao   +17 more
wiley   +1 more source

Recombinant human thrombopoietin as a novel platelet-driven regulator accelerating hepatic regeneration in acute liver failure. [PDF]

Front Pharmacol
Shen Y, Han F, Wang T, Jing L, Luo Y, Ha F, Lu Y, Liang J.   +7 more
europepmc   +1 more source

Cytokine‐Engineered Chimeric Antigen Receptor‐T Cell Therapy: How to Balance the Efficacy and Toxicity

Advanced Science, EarlyView.
Cytokine‐engineered CAR‐T cells represent a promising immunotherapy against malignancies due to direct tumor killing and potent immunity response. However, significant toxicities, including CRS and ICANS, have restricted clinical applications. How to keep the risk‐benefit balance of the advanced therapy is of great importance for maximizing the benefit
Xinru Zhang, Gulizeba Aimaiti, Yuanye Guan, Yuzhe Sha, Wei Zhou, Jiefeng Shen, Bo Zhao, Wei‐En Yuan   +7 more
wiley   +1 more source

Contributions of selenoproteins to breast cancer etiology and racial disparity. [PDF]

Cancer Causes Control
Bera S, Liu L, Ma W, Xu Z, Sverdlov M, Deaton R, Macias V, Valyi-Nagy K, Kajdacsy-Balla A, Hoskins K, Wiley EL, Kastrati I, Diamond AM.   +12 more
europepmc   +1 more source

Expression of Glutamatergic Signaling in Canine Oral Melanocytic Neoplasms. [PDF]

Vet Sci
Masyr A, Pluemhathaikij L, Wang S, Thaiwong-Nebelung T, Smedley RC.   +4 more
europepmc   +1 more source

Polarized Distribution of Lipid Droplets with Long Acyl Chains and Unsaturation are Hallmarks of Human Intestinal Enteroid Differentiation. [PDF]

Anal Chem
Johansson PK, Liu Y, Klett KC, Heilshorn SC, Enejder A.   +4 more
europepmc   +1 more source

Lack of cytoplasmic expression of a new marker programmed cell death ligand-1 in tumor cells is significant. [PDF]

World J Exp Med
Senchukova MA, Zubareva EY, Saidler NV, Krivolapova LV.   +3 more
europepmc   +1 more source

Unlocking the Tumor Microenvironment: Innovations in Multiplex Immunohistochemistry. [PDF]

Cells
Gupta B, Yang G, Key M.
europepmc   +1 more source